DarioHealth (DRIO) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Alliance Global Partners | Initiated Coverage | Buy | $12.00 | Aug 19, 2026 |
| TD Cowen | Maintained | Hold | $8.00 from $11.00 | Aug 12, 2026 |
| Stifel | Maintained | Buy | $10.00 | May 14, 2026 |
| Stifel | Maintained | Buy | $10.00 from $16.00 | Mar 20, 2026 |
| Litchfield Hills | Initiated Coverage | Buy | $3.00 | May 19, 2025 |
| Stifel | Maintained | Buy | $2.00 from $3.50 | Mar 11, 2025 |
| Stifel | Maintained | Buy | $4.00 | Apr 1, 2024 |
| Alliance Global Partners | Maintained | Buy | $4.10 from $5.45 | Aug 11, 2023 |
| Stifel | Maintained | Buy | $6.00 from $9.00 | Jul 25, 2023 |
| Craig-Hallum | Maintained | Buy | $8.00 from $14.00 | May 12, 2023 |
Frequently asked questions
Is DRIO a buy, sell, or hold?
Analysts covering DarioHealth currently average a Buy rating: 3 buy, 1 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on DRIO?
On Aug 19, 2026, Alliance Global Partners initiated coverage of DarioHealth at Buy with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.